title: Hemiballismus in subthalamic haemorrhage: efficacy of levetiracetam.
authors.forename: P
authors.initials: P
authors.lastname: Marchione
authors.forename: C
authors.initials: C
authors.lastname: Vento
authors.forename: M
authors.initials: M
authors.lastname: Marianetti
authors.forename: T
authors.initials: T
authors.lastname: Romeo
authors.forename: G A
authors.initials: GA
authors.lastname: Amabile
authors.forename: P
authors.initials: P
authors.lastname: Giacomini
mesh_terms: D000368:Aged; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000008:administration & dosage*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001259:Ataxia / Q000209:etiology; D002531:Cerebellum / Q000473:pathology / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D020820:Dyskinesias / Q000188:drug therapy* / Q000473:pathology* / Q000503:physiopathology; D006220:Haloperidol / Q000627:therapeutic use; D020786:Hemangioma, Cavernous, Central Nervous System / Q000150:complications / Q000473:pathology; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D020299:Intracranial Hemorrhage, Hypertensive / Q000150:complications*; D000077287:Levetiracetam; D008140:Lorazepam / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D010889:Piracetam / Q000008:administration & dosage / Q000031:analogs & derivatives*; D012008:Recurrence; D020531:Subthalamic Nucleus / Q000098:blood supply / Q000473:pathology* / Q000503:physiopathology; D016896:Treatment Outcome; D014839:Vomiting / Q000209:etiology
chemical_list: D018726:Anti-Dyskinesia Agents; D000927:Anticonvulsants; D000959:Antihypertensive Agents; D000077287:Levetiracetam; D006220:Haloperidol; D008140:Lorazepam; D010889:Piracetam